StockData
Panacea Life Sciences Holdings, Inc. logo

Panacea Life Sciences Holdings, Inc. (PLSH) stock

PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)

Close on Oct 19, 2026Market cap $1.15MP/E –Yield –

Panacea Life Sciences enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Panacea Life Sciences's enterprise value was $1.16M on Oct 19, 2026, against $1.16M a year earlier. Over the last 5 years it ranged from -$1.22M to $7.06M, with a median of $1.16M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$1.16M+45.0%
2025Dec 31, 2025$798.42K+134.4%
2024Dec 31, 2024$340.64K-86.7%
2023Dec 29, 2023$2.57M–
2022Dec 30, 2022-$100.27K–

More Panacea Life Sciences figures

See a number that looks wrong?